Pathology & Laboratory Medicine

Publications

Filter By Faculty

Filter by Principal Investigator

2003

Lafuente MJ, Martin P, Garcia-Cao I, Diaz-Meco MT, Serrano M, Moscat J. Regulation of mature T lymphocyte proliferation and differentiation by Par-4. EMBO J. 2003;22(18):4689-98.

Chanan-Khan A, Holkova B, Perle MA, Reich E, C Wu D, Inghirami G, et al. T-cell clonality and myelodysplasia without chromosomal fragility in a patient with features of Seckel syndrome. Haematologica. 2003;88(5):ECR14.

Kiani B, Magro CM, Ross P. Endobronchial presentation of Hodgkin lymphoma: a review of the literature. Ann Thorac Surg. 2003;76(3):967-72.

Agnese DM, Abdessalam SF, Burak WE, Magro CM, Pozderac RV, Walker MJ. Cost-effectiveness of sentinel lymph node biopsy in thin melanomas. Surgery. 2003;134(4):542-7; discussion 547-8.

Jang B-, Muñoz-Najar U, Paik J-, Claffey K, Yoshida M, Hla T. Leptomycin B, an inhibitor of the nuclear export receptor CRM1, inhibits COX-2 expression. J Biol Chem. 2003;278(5):2773-6.

Chen X, DeLellis RA, Hoda SA. Adrenoleukodystrophy. Arch Pathol Lab Med. 2003;127(1):119-20.

Wusirika R, Ferri C, Marin M, Knight DA, W Waldman J, Ross P, et al. The assessment of anti-endothelial cell antibodies in scleroderma-associated pulmonary fibrosis. A study of indirect immunofluorescent and western blot analysis in 49 patients with scleroderma. Am J Clin Pathol. 2003;120(4):596-606.

A Crowson N, Nuovo GJ, Mihm MC, Magro C. Cutaneous manifestations of Crohn's disease, its spectrum, and its pathogenesis: intracellular consensus bacterial 16S rRNA is associated with the gastrointestinal but not the cutaneous manifestations of Crohn's disease. Hum Pathol. 2003;34(11):1185-92.

A Crowson N, Nuovo G, Ferri C, Magro CM. The dermatopathologic manifestations of hepatitis C infection: a clinical, histological, and molecular assessment of 35 cases. Hum Pathol. 2003;34(6):573-9.

Muthukumar T, Ding R, Dadhania D, Medeiros M, Li B, Sharma VK, et al. Serine proteinase inhibitor-9, an endogenous blocker of granzyme B/perforin lytic pathway, is hyperexpressed during acute rejection of renal allografts. Transplantation. 2003;75(9):1565-70.